Pharmacists in Blackwell, OK Accepting Medicare
6 Pharmacists found. Showing 1 - 6
 Dr. Jennifer Elisabeth Prater, DPH Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 1219 W Doolin Ave, Blackwell, OK 74631 Phone: 580-363-4090 Fax: 580-363-1390 |
Caryen Leemarie Fergeson, RPH Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 119 N Main St, Blackwell, OK 74631 Phone: 580-363-2137 Fax: 580-363-5582 |
 Dennis William Hutton Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 419 Bel Air Ave, Blackwell, OK 74631 Phone: 580-363-0755 Fax: 580-363-5582 |
Dr. Justun Kukuk, PHARMD Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 119 N Main St, Blackwell, OK 74631 Phone: 580-363-2137 |
Dr. Clark Bishop, PHARMD Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 119 N Main St, Blackwell, OK 74631 Phone: 580-363-2137 |
Dr. Jay Edward Hopkins, PHARM.D. Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 1219 W Doolin Ave, Blackwell, OK 74631 Phone: 580-363-4090 Fax: 580-363-1390 |
News Archive
Text-message intervention may help boost flu vaccination rates in children
Text message reminders to parents about flu vaccinations may help boost the number of children vaccinated, according to researchers at Columbia University Medical Center and NewYork-Presbyterian Hospital. Full study findings are reported in the April 25 issue of the Journal of the American Medical Association.
Scientists report first preliminary description of bed bug's sialome
With bed bugs reemerging as a nuisance in some parts of the country, scientists are reporting the first preliminary description of the bug's sialome - the saliva proteins that are the secret to Cimex lectularius' ability to suck blood from its human victims and escape to bite again with risking a lethal slap. The findings, which could have medical applications in diagnosing bed bug bites and preventing the itch, appear in ACS' monthly Journal of Proteome Research.
Genzyme announces 2-year data from eliglustat tartrate Phase 2 trial for Gaucher disease
Genzyme Corporation announced today two-year follow-up data from patients enrolled in the phase 2 clinical trial for its investigational oral therapy for Gaucher disease type 1 known as eliglustat tartrate (formerly Genz-112638). Continued improvements were observed across all endpoints, including bone disease, at the two-year timepoint, compared with baseline. The two-year results were presented for the first time today at the Lysosomal Disease Network WORLD Symposium in Miami, Fla.
ESP will open new doors into music for non-musicians
A new University of Southern California computer system lets a user "drive" a piece of music, using a wheel and foot controls. The Expression Synthesis Project (ESP) interface, devised by a team led by Elaine Chew of the USC Viterbi School of Engineering, could be in the hands of consumers within two years.
› Verified 5 days ago